Samsung Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Samsung Pharmaceutical Co. Ltd.
Vanguard Total International Stock Index Fund
630,804
1.09%
0
0%
07/31/2018
Vanguard Developed Markets Index Fund
243,462
0.42%
0
0%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
180,494
0.31%
19,918
0%
04/30/2018
Vanguard FTSE All World (ex-US) Small Cap
117,521
0.2%
0
0.01%
07/31/2018
Government Pension Fund - Global (The)
111,056
0.19%
111,056
0%
12/31/2017
DFA Emerging Markets Small Cap Series
87,881
0.15%
11,330
0%
01/31/2018
SPDR S&P International Small Cap ETF
47,334
0.08%
0
0.02%
09/06/2018
Vanguard Pacific Stock Index Fund
36,622
0.06%
0
0%
07/31/2018
Old Westbury Small & Mid Cap Fund
7,427
0.01%
0
0%
04/30/2018
6,700
0.01%
2,963
0.01%
04/30/2018
| Address |
35 Jeyakgongdan 2-gil
Hwaseong-si GY 18622
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.sspharm.co.kr |
| Updated |
07/08/2019 |
| Samsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. It operates through the following business divisions: Pharmaceutical, Cosmetics, and Healthy Food. The Pharmaceutical divsion provides medicines for digestion, antibiotics, intestine, alleviation of fever, and cerebral apoplexy. |
